CTMX icon

CytomX Therapeutics
CTMX

Overview Fund Activity

49 hedge funds and large institutions have $226M invested in CytomX Therapeutics in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 19 increasing their positions, 11 reducing their positions, and 6 closing their positions.

Holders
49
Holders Change
+1
Holders Change %
+2.08%
% of All Funds
1.31%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
7
Increased
19
Reduced
11
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
PA
1
Perceptive Advisors
New York
$9.57M
2
GC
2
Globeflex Capital
California
$761K
3
EAM
3
Eventide Asset Management
Massachusetts
$1.94M
4
CS
4
Candriam SCA
Luxembourg
$539K
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$2.97M

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$0
2
D.E. Shaw & Co
2
D.E. Shaw & Co
New York
$0
3
VMI
3
VHCP Management II
New York
$7.43M
4
Goldman Sachs
4
Goldman Sachs
New York
$0
5
QSS
5
Quantitative Systematic Strategies
Florida
$0
Name Market Value Shares Shares
Change 		Shares
Change %
D.E. Shaw & Co
51
D.E. Shaw & Co
New York
– – -21,257 Closed
Goldman Sachs
52
Goldman Sachs
New York
– – -15,278 Closed
QSS
53
Quantitative Systematic Strategies
Florida
– – -14,409 Closed
BNP Paribas Financial Markets
54
BNP Paribas Financial Markets
France
– – -1,376 Closed
Barclays
55
Barclays
United Kingdom
– – -167 Closed
1 2
3